ArticleHuman cell2022

Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine.

Yi-Ting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.